Trial Profile
ONO-4059 phase II study: Multicenter, open-label, uncontrolled, single-arm study in patients with refractory pemphigus
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Sep 2022
Price :
$35
*
At a glance
- Drugs Tirabrutinib (Primary)
- Indications Pemphigus
- Focus Therapeutic Use
- Sponsors Ono Pharmaceutical
- 02 Sep 2022 Planned End Date changed from 1 Jan 2023 to 31 Dec 2026.
- 01 Sep 2021 Status changed to completed, as per results published in the Journal of Dermatological Science
- 17 Dec 2018 New trial record